50.93
Inspire Medical Systems Inc stock is traded at $50.93, with a volume of 944.84K.
It is up +3.54% in the last 24 hours and up +11.40% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
See More
Previous Close:
$49.19
Open:
$50.17
24h Volume:
944.84K
Relative Volume:
0.84
Market Cap:
$1.47B
Revenue:
$915.25M
Net Income/Loss:
$131.14M
P/E Ratio:
11.39
EPS:
4.472
Net Cash Flow:
$96.71M
1W Performance:
-4.39%
1M Performance:
+11.40%
6M Performance:
-37.73%
1Y Performance:
-60.48%
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INSP
Inspire Medical Systems Inc
|
50.93 | 1.42B | 915.25M | 131.14M | 96.71M | 4.472 |
|
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-12-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-12-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-26 | Downgrade | Truist | Buy → Hold |
| Dec-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-26-25 | Upgrade | Truist | Hold → Buy |
| Nov-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-24-25 | Upgrade | Stifel | Hold → Buy |
| Nov-04-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-24-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
Form 4 Inspire Medical Systems Inc For: 27 July By Investing.com - Investing.com Canada
Inspire Medical Systems (NYSE: INSP) awards 5,631 RSUs to board member Carrel - Stock Titan
Inspire Medical Systems, Inc. (INSP) director files initial Form 3 with no holdings - Stock Titan
AtriCure CEO Carrel joins Inspire Medical board of directors - MassDevice
Inspire Medical (2DR) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
Inspire Medical Systems adds AtriCure CEO to board - Investing.com
Inspire Medical Systems adds AtriCure CEO to board By Investing.com - Investing.com South Africa
Inspire's New Director Comes From AtriCure, Which Helped Over 1M Patients - Stock Titan
Inspire Medical Systems Inc (INSP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inspire Medical Systems Inc (INSP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inspire Medical Systems Inc (INSP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inspire Medical (2DR) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
Inspire Medical (2DR) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Inspire Medical Systems, Inc. (INSP) Stock Forecasts - Yahoo! Finance Canada
TradingKey - TradingKey
INSP|Inspire Medical Systems Inc|Price:49.750|Chg%:+0.560 - TradingKey
Inspire Medical Systems, Inc. Revenue Breakdown – BOATS:INSP - TradingView
Inspire Medical Systems Inc (INSP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inspire Medical Systems (INSP) Refreshes Its Board, Is It Still Below Fair Value? - Sahm
INSP|Inspire Medical Systems Inc|Price:49.190|Chg%:-1.620 - TradingKey
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc.INSP - marketscreener.com
INSP|Inspire Medical Systems Inc|Price:50.760|Chg%:+0.360 - TradingKey
Inspire Medical names AtriCure CEO Michael Carrel to board - Bitget
Inspire Medical board member Tansey to retire July 30 By Investing.com - Investing.com Canada
Inspire Medical board member Tansey to retire July 30 - Investing.com
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors - The Manila Times
Casey Tansey to Retire from Inspire's Board, Effective July 30, 2026 - TradingView
After more than 18 years, Casey Tansey to retire from Inspire board - Stock Titan
Inspire Medical Systems (INSP) Q4 2024 earnings summary - Quartr
Inspire Medical (INSP) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
1 Billion People Suffer From Sleep Apena. The Future of Treatment Is No Longer Just CPAP. - Men's Health
A Look at Inspire Medical Systems Inc (INSP) After 5.3% Gain -- GF Value $215.85 vs Price $53.27 - GuruFocus
Form 4 Inspire Medical Systems Inc For: 20 July By Investing.com - Investing.com Nigeria
3 Medical Device Stocks Giving Investors a Different Healthcare Play - MarketBeat
Here's why you should retain INSP stock in your portfolio for now - MSN
Understanding Momentum Shifts in (INSP) - Stock Traders Daily
Price to earnings forward of Inspire Medical Systems, Inc. – NYSE:INSP - TradingView
Enterprise value to EBITDA forward of Inspire Medical Systems, Inc. – NYSE:INSP - TradingView
Form 4 Inspire Medical Systems Inc For: 17 July By Investing.com - Investing.com South Africa
Form 4 Inspire Medical Systems Inc For: 17 July - Investing.com India
Inspire Medical Systems (NYSE: INSP) director receives 581-share stock fee award - Stock Titan
Inspire Medical Systems (INSP) grants director 383 common shares as fees - Stock Titan
ETFs Investing in Inspire Medical Systems, Inc. Stocks - TradingView
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Yahoo Finance
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $54 - Moomoo
Inspire Medical (INSP) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
INSP Maintained by Truist Securities -- Price Target Raised to $54 - GuruFocus
Truist Adjusts Price Target on Inspire Medical Systems to $54 From $50, Maintains Hold Rating - Moomoo
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Potential Amidst Robust Revenue Growth in the Medical Device Sector - DirectorsTalk Interviews
INSP Should I Buy - Intellectia AI
Enterprise value to EBIT forward of Inspire Medical Systems, Inc. – NYSE:INSP - TradingView
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):